Gel Column Agglutination Test System Market Share

Statistics for the 2023 & 2024 Gel Column Agglutination Test System market share, created by Mordor Intelligence™ Industry Reports. Gel Column Agglutination Test System share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Gel Column Agglutination Test System Industry

The market studied is moderately competitive and there are several international companies that are having an active presence in this market. Some of the companies which are currently gaining attention include, Bio-Rad Laboratories, Inc., Grifols, QIAGEN, Ortho Clinical Diagnostics, Tulip Diagnostics (P) Ltd, Thermo Fisher Scientific, 3B scientific and Mira Vista Labs.

Gel Column Agglutination Test System Market Leaders

  1. QIAGEN

  2. Ortho Clinical Diagnostics

  3. Grifols

  4. Bio-Rad Laboratories, Inc.

  5. Tulip Diagnostics (P) Ltd

*Disclaimer: Major Players sorted in no particular order

Bio-Rad Laboratories, Inc., Grifols, QIAGEN, Ortho Clinical Diagnostics, Tulip Diagnostics (P) Ltd, Thermo Fisher Scientific

Gel Column Agglutination Test system market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)